8:10am ET
Investing
Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
A clinical-stage radiopharmaceutical startup with no product revenue just caught the attention of three of pharma's biggest acquirers, and the rights structure hiding inside its Lilly partnership may explain exactly why.
